Assessing the potential causal effects of 1099 plasma metabolites on 2099 binary disease endpoints

Metabolites are small molecules that are useful for estimating disease risk and elucidating disease biology. Here, we perform two-sample Mendelian randomization to systematically infer the potential causal effects of 1099 plasma metabolites measured in 6136 Finnish men from the METSIM study on risk of 2099 binary disease endpoints measured in 309,154 Finnish individuals from FinnGen. We find evidence for 282 putative causal effects of 70 metabolites on 183 disease endpoints. We also identify 25 metabolites with potential causal effects across multiple disease domains, including ascorbic acid 2-sulfate affecting 26 disease endpoints in 12 disease domains. Our study suggests that N-acetyl-2-aminooctanoate and glycocholenate sulfate affect risk of atrial fibrillation through two distinct metabolic pathways and that N-methylpipecolate may mediate the putative causal effect of N6,N6-dimethyllysine on anxious personality disorder.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-03-28
DOI
https://doi.org/10.1038/s41467-025-58129-2
Citations
2
Primary Topic
Genetic Associations and Epidemiology
Type
article
Field-Weighted Citation Impact
3.63

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Assessing the potential causal effects of 1099 plasma metabolites on 2099 binary disease endpoints

Michael Boehnke, Debraj Bose, Laura J. Scott, Lilian Fernandes Silva et al.
2 citations
Nature Communications
Genetic Associations and Epidemiology
3.63
article

Assessing the potential causal effects of 1099 plasma metabolites on 2099 binary disease endpoints

Michael Boehnke, Debraj Bose, Laura J. Scott, Lilian Fernandes Silva, Anne Jackson, Anniina Oravilahti, Heather M. Stringham, Xianyong Yin, Charles Burant, Jean Morrison, Jeffrey Okamoto, Zhi‐Jie Xia, Samuli Ripatti, Annie Kwon, Ru‐Wen Peng, Aarno V. Palotie, Xiaoquan Wen, Lei Liu, Eric B. Fauman, Markku Laakso, Mark J. Daly, Xiaomeng Chu, Jack Li
article en
2 citations

Abstract

Metabolites are small molecules that are useful for estimating disease risk and elucidating disease biology. Here, we perform two-sample Mendelian randomization to systematically infer the potential causal effects of 1099 plasma metabolites measured in 6136 Finnish men from the METSIM study on risk of 2099 binary disease endpoints measured in 309,154 Finnish individuals from FinnGen. We find evidence for 282 putative causal effects of 70 metabolites on 183 disease endpoints. We also identify 25 metabolites with potential causal effects across multiple disease domains, including ascorbic acid 2-sulfate affecting 26 disease endpoints in 12 disease domains. Our study suggests that N-acetyl-2-aminooctanoate and glycocholenate sulfate affect risk of atrial fibrillation through two distinct metabolic pathways and that N-methylpipecolate may mediate the putative causal effect of N6,N6-dimethyllysine on anxious personality disorder.

Nature CommunicationsVol. 16(1)
Broad Institute (US), University of Helsinki (FI), University of Eastern Finland (FI), Pfizer (United States) (US), University of Michigan (US), Massachusetts General Hospital (US), Kuopio University Hospital (FI), Institute for Molecular Medicine Finland (FI), Statistical Service (CY), Nanjing Medical University (CN)
American Diabetes Association
Zero hunger
Openalex Percentile: Top 9%
Genetic Associations and Epidemiology
3.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.